Literature DB >> 21193192

Antral follicle count provides additive information to hormone measures for determining ovarian function in breast cancer survivors.

H Irene Su1, Karine Chung, Mary D Sammel, Clarisa R Gracia, Angela DeMichele.   

Abstract

In breast cancer survivors, antral follicle count appears to provide data on ovarian function that are independent of antimullerian hormone, FSH, and inhibin B. Therefore, ultrasound appears to be a tool that may not only corroborate, but also add to the accuracy of hormone measures for determining ovarian function in breast cancer survivors.
Copyright © 2011 American Society for Reproductive Medicine. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 21193192      PMCID： PMC3062716          DOI： 10.1016/j.fertnstert.2010.12.005

Source DB:  PubMed          Journal:  Fertil Steril        ISSN： 0015-0282            Impact factor:   7.329


  13 in total

Review 1.  A systematic review of tests predicting ovarian reserve and IVF outcome.

Authors:  F J Broekmans; J Kwee; D J Hendriks; B W Mol; C B Lambalk
Journal:  Hum Reprod Update       Date:  2006-08-04       Impact factor: 15.610

Review 2.  Fertility in female cancer survivors: pathophysiology, preservation and the role of ovarian reserve testing.

Authors:  Kerryn Lutchman Singh; Melanie Davies; Ratna Chatterjee
Journal:  Hum Reprod Update       Date:  2004-11-29       Impact factor: 15.610

3.  Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials.

Authors: 
Journal:  Lancet       Date:  2005 May 14-20       Impact factor: 79.321

4.  Web-based survey of fertility issues in young women with breast cancer.

Authors:  Ann H Partridge; Shari Gelber; Jeffrey Peppercorn; Ebonie Sampson; Katherine Knudsen; Marc Laufer; Randi Rosenberg; Michele Przypyszny; Alison Rein; Eric P Winer
Journal:  J Clin Oncol       Date:  2004-10-15       Impact factor: 44.544

5.  Ovarian reserve in women who remain premenopausal after chemotherapy for early stage breast cancer.

Authors:  Ann H Partridge; Kathryn J Ruddy; Shari Gelber; Lidia Schapira; Mary Abusief; Meghan Meyer; Elizabeth Ginsburg
Journal:  Fertil Steril       Date:  2009-05-05       Impact factor: 7.329

6.  Incidence, time course, and determinants of menstrual bleeding after breast cancer treatment: a prospective study.

Authors:  Jeanne A Petrek; Michelle J Naughton; L Douglas Case; Electra D Paskett; Elizabeth Z Naftalis; S Eva Singletary; Paniti Sukumvanich
Journal:  J Clin Oncol       Date:  2006-02-13       Impact factor: 44.544

7.  A pilot study of predictive markers of chemotherapy-related amenorrhea among premenopausal women with early stage breast cancer.

Authors:  Carey Anders; P Kelly Marcom; Bercedis Peterson; Lin Gu; Sue Unruhe; Renee Welch; Peggy Lyons; Millie Behera; Susannah Copland; Gretchen Kimmick; Heather Shaw; Stacey Snyder; Monica Antenos; Teresa Woodruff; Kimberly Blackwell
Journal:  Cancer Invest       Date:  2008 Apr-May       Impact factor: 2.176

8.  Breast cancer in younger women: reproductive and late health effects of treatment.

Authors:  Patricia A Ganz; Gail A Greendale; Laura Petersen; Barbara Kahn; Julienne E Bower
Journal:  J Clin Oncol       Date:  2003-11-15       Impact factor: 44.544

9.  Epidemiologic evaluation of measurement data in the presence of detection limits.

Authors:  Jay H Lubin; Joanne S Colt; David Camann; Scott Davis; James R Cerhan; Richard K Severson; Leslie Bernstein; Patricia Hartge
Journal:  Environ Health Perspect       Date:  2004-12       Impact factor: 9.031

10.  Predictors of ovarian reserve in young women with breast cancer.

Authors:  K Lutchman Singh; S Muttukrishna; R C Stein; H H McGarrigle; A Patel; B Parikh; N P Groome; M C Davies; R Chatterjee
Journal:  Br J Cancer       Date:  2007-05-29       Impact factor: 7.640
View more
  5 in total

1.  Impact of tamoxifen therapy on fertility in breast cancer survivors.

Authors:  Lisa M Shandley; Jessica B Spencer; Amy Fothergill; Ann C Mertens; Amita Manatunga; Elisavet Paplomata; Penelope P Howards
Journal:  Fertil Steril       Date:  2016-11-22       Impact factor: 7.329

2.  Prediction of postchemotherapy ovarian function using markers of ovarian reserve.

Authors:  N Lynn Henry; Rong Xia; Anne F Schott; Daniel McConnell; Mousumi Banerjee; Daniel F Hayes
Journal:  Oncologist       Date:  2013-12-06

3.  Fertility in female survivors of Hodgkin's lymphoma.

Authors:  Irene Biasoli; Simona Falorio; Stefano Luminari; Nelson Spector; Massimo Federico
Journal:  Rev Bras Hematol Hemoter       Date:  2012

4.  The utility of anti-Müllerian hormone in the diagnosis and prediction of loss of ovarian function following chemotherapy for early breast cancer.

Authors:  R A Anderson; J Mansi; R E Coleman; D J A Adamson; R C F Leonard
Journal:  Eur J Cancer       Date:  2017-11-05       Impact factor: 9.162

5.  Adverse reproductive health outcomes in a cohort of young women with breast cancer exposed to systemic treatments.

Authors:  Cristina Silva; Ana Cristina Ribeiro Rama; Sérgio Reis Soares; Mariana Moura-Ramos; Teresa Almeida-Santos
Journal:  J Ovarian Res       Date:  2019-10-31       Impact factor: 4.234
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.